These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 32078147)

  • 1. Intramuscular Clodronate in Long-Term Treatment of Symptomatic Knee Osteoarthritis: A Randomized Controlled Study.
    Frediani B; Toscano C; Falsetti P; Nicosia A; Pierguidi S; Migliore A; Giannotti S; Cantarini L; Conticini E
    Drugs R D; 2020 Mar; 20(1):39-45. PubMed ID: 32078147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra-articular clodronate for the treatment of knee osteoarthritis: dose ranging study vs hyaluronic acid.
    Rossini M; Viapiana O; Ramonda R; Bianchi G; Olivieri I; Lapadula G; Adami S
    Rheumatology (Oxford); 2009 Jul; 48(7):773-8. PubMed ID: 19406908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary study of highly cross-linked hyaluronic acid-based combination therapy for management of knee osteoarthritis-related pain.
    Palmieri B; Rottigni V; Iannitti T
    Drug Des Devel Ther; 2013; 7():7-12. PubMed ID: 23326188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of intra-articular clodronate in the treatment of knee osteoarthritis: results of a double-blind, randomized placebo-controlled trial.
    Rossini M; Adami S; Fracassi E; Viapiana O; Orsolini G; Povino MR; Idolazzi L; Gatti D
    Rheumatol Int; 2015 Feb; 35(2):255-63. PubMed ID: 25080876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of clodronate for painful knee prosthesis in osteoarthritis patients: a 6-month pilot study.
    Saviola G; Ferrari P; Niccolò E; Casabella A; Ghellere F; Bonazzi S; Lul AA; Comini L; Molfetta L
    Minerva Med; 2020 Dec; 111(6):551-559. PubMed ID: 32573517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intramuscular clodronate in erosive osteoarthritis of the hand is effective on pain and reduces serum COMP: a randomized pilot trial-The ER.O.D.E. study (ERosive Osteoarthritis and Disodium-clodronate Evaluation).
    Saviola G; Abdi-Ali L; Povino MR; Campostrini L; Sacco S; Dalle Carbonare L; Carbonare LD
    Clin Rheumatol; 2017 Oct; 36(10):2343-2350. PubMed ID: 28536825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Twice-a-month" clodronate 200 mg IM: a new dosing regimen and improved therapy adherence in the treatment of postmenopausal osteoporosis.
    Muratore M; Quarta L; Calcagnile F; Quarta E
    Adv Ther; 2010 May; 27(5):314-20. PubMed ID: 20526703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-articular clodronate in patients with knee osteoarthritis non-responder to intra-articular hyaluronic acid - a case report series of 9 patients with 8-month follow-up.
    Saviola G; Da Campo G; Bianchini MC; Abdi-Ali L; Comini L; Rosini S; Molfetta L
    Clin Ter; 2023; 174(3):245-248. PubMed ID: 37199358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clodronate and hydroxychloroquine in erosive osteoarthritis: a 24-month open randomized pilot study.
    Saviola G; Abdi-Ali L; Campostrini L; Sacco S; Baiardi P; Manfredi M; Mannoni A; Benucci M
    Mod Rheumatol; 2012 Apr; 22(2):256-63. PubMed ID: 21853386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical effect of intramuscular calcitonin compared with oral celecoxib in the treatment of knee bone marrow lesions: a retrospective study.
    Zhou J; Xiong W; Gou P; Chen Z; Guo X; Huo X; Xue Y
    J Orthop Surg Res; 2020 Jun; 15(1):230. PubMed ID: 32576210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermittent intramuscular clodronate therapy: a valuable option for older osteoporotic women.
    Dominguez LJ; Galioto A; Ferlisi A; Alessi MA; Belvedere M; Putignano E; Costanza G; Bevilacqua M; Barbagallo M
    Age Ageing; 2005 Nov; 34(6):633-6. PubMed ID: 16267191
    [No Abstract]   [Full Text] [Related]  

  • 12. Zoledronic acid reduces knee pain and bone marrow lesions over 1 year: a randomised controlled trial.
    Laslett LL; Doré DA; Quinn SJ; Boon P; Ryan E; Winzenberg TM; Jones G
    Ann Rheum Dis; 2012 Aug; 71(8):1322-8. PubMed ID: 22355040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic and tolerability of i.m. disodium clodronate 200 mg/lidocaine 1%, given twice monthly, in comparison with i.m. disodium clodronate 100 mg/lidocaine 1%, given weekly, in healthy postmenopausal female patients.
    Radicioni M; Cremonesi G; Baraldi E; Leuratti C; Mariotti F
    Int J Clin Pharmacol Ther; 2013 Apr; 51(4):313-22. PubMed ID: 23357844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of clodronate on synovial fluid levels of some inflammatory mediators, after intra-articular administration to patients with synovitis secondary to knee osteoarthritis.
    Cocco R; Tofi C; Fioravanti A; Nerucci F; Nannipieri F; Zampieri A; Rosini S; Marcolongo R
    Boll Soc Ital Biol Sper; 1999; 75(11-12):71-6. PubMed ID: 11433681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clodronate in the management of different musculoskeletal conditions.
    Frediani B; Giusti A; Bianchi G; Dalle Carbonare L; Malavolta N; Cantarini L; Saviola G; Molfetta L
    Minerva Med; 2018 Aug; 109(4):300-325. PubMed ID: 29947493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of low-dose transdermal buprenorphine patches (5, 10, and 20 microg/h) versus prolonged-release tramadol tablets (75, 100, 150, and 200 mg) in patients with chronic osteoarthritis pain: a 12-week, randomized, open-label, controlled, parallel-group noninferiority study.
    Karlsson M; Berggren AC
    Clin Ther; 2009 Mar; 31(3):503-13. PubMed ID: 19393841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of intravenous pamidronate and oral clodronate on symptoms and bone resorption in patients with metastatic bone disease.
    Jagdev SP; Purohit P; Heatley S; Herling C; Coleman RE
    Ann Oncol; 2001 Oct; 12(10):1433-8. PubMed ID: 11762816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
    Kivitz A; Ma C; Ahdieh H; Galer BS
    Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clodronate therapy of metastatic bone disease in patients with prostatic carcinoma.
    Adami S; Mian M
    Recent Results Cancer Res; 1989; 116():67-72. PubMed ID: 2527401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can clodronate be effective in the treatment of disabling hydroxyapatite crystal-deposition disease? A report of two cases.
    Saviola G; Abdi-Ali L; Baiardi P; Benucci M
    Rheumatol Int; 2011 Mar; 31(3):415-7. PubMed ID: 20665030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.